CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling

Cancer Letters

Volumn 358, Issue 2, 2015, Pages 124-135

  Zhou, Shao Lai ^a   Zhou, Zheng Jun ^a   Hu, Zhi Qiang ^a   Li, Xun ^a   Huang, Xiao Wu ^a   Wang, Zheng ^a   Fan, Jia ^a   Dai, Zhi ^a   Zhou, Jian ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

CXCL5; CXCR2; Epithelial mesenchymal transition; Hepatocellular carcinoma; Metastasis

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR SNAIL; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; CELL INVASION; CELL INVASION ASSAY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR XENOGRAFT; WESTERN BLOTTING; AGED; ANIMAL; CANCER GRADING; CANCER STAGING; DISEASE COURSE; DISEASE MODEL; GENE EXPRESSION; GENETICS; LIVER TUMOR; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE; TUMOR VOLUME; XENOGRAFT;

ADULT; AGED; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHEMOKINE CXCL5; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GLYCOGEN SYNTHASE KINASE 3; HETEROGRAFTS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; PHOSPHATIDYLINOSITOL 3-KINASES; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, INTERLEUKIN-8B; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR BURDEN;

EID: 84921611532     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.11.044     Document Type: Article

References (35)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J. Clin 2012, 62:10-29.
2. Sherman M. Recurrence of hepatocellular carcinoma. N. Engl. J. Med 2008, 359:2045-2047.
3. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
4. Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat. Rev. Cancer 2007, 7:415-428.
5. Grunert S., Jechlinger M., Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol 2003, 4:657-665.
6. Iwatsuki M., Mimori K., Yokobori T., Ishi H., Beppu T., Nakamori S., et al. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 2010, 101:293-299.
7. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
8. Ansieau S., Bastid J., Doreau A., Morel A.P., Bouchet B.P., Thomas C., et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 2008, 14:79-89.
9. Kudo-Saito C., Shirako H., Takeuchi T., Kawakami Y. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 2009, 15:195-206.
10. Zhou Z.J., Dai Z., Zhou S.L., Hu Z.Q., Chen Q., Zhao Y.M., et al. HNRNPAB induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by transcriptionally activating SNAIL. Cancer Res 2014, 74:2750-2762.
11. Yang M.H., Chen C.L., Chau G.Y., Chiou S.H., Su C.W., Chou T.Y., et al. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 2009, 50:1464-1474.
12. Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer 2004, 4:540-550.
13. Mantovani A., Savino B., Locati M., Zammataro L., Allavena P., Bonecchi R. The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev 2010, 21:27-39.
14. Zhou S.L., Dai Z., Zhou Z.J., Wang X.Y., Yang G.H., Wang Z., et al. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology 2012, 56:2242-2254.
15. Saintigny P., Massarelli E., Lin S., Ahn Y.H., Chen Y., Goswami S., et al. CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma. Cancer Res 2013, 73:571-582.
16. Singh S., Sadanandam A., Varney M.L., Nannuru K.C., Singh R.K. Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion. Int. J. Cancer 2010, 126:328-336.
17. Matsuo Y., Raimondo M., Woodward T.A., Wallace M.B., Gill K.R., Tong Z., et al. CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer. Int. J. Cancer 2009, 125:1027-1037.
18. Li Y., Tian B., Yang J., Zhao L., Wu X., Ye S.L., et al. Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics. J. Cancer Res. Clin. Oncol 2004, 130:460-468.
19. Ye Q.H., Qin L.X., Forgues M., He P., Kim J.W., Peng A.C., et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat. Med 2003, 9:416-423.
20. Wen W., Ding J., Sun W., Fu J., Chen Y., Wu K., et al. Cyclin G1-mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase/Akt signaling facilitates liver cancer progression. Hepatology 2012, 55:1787-1798.
21. Wittekind C. [Pitfalls in the classification of liver tumors]. Pathologe 2006, 27:289-293.
22. Sun H.C., Zhang W., Qin L.X., Zhang B.H., Ye Q.H., Wang L., et al. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. J. Hepatol 2007, 47:684-690.
23. Yang X.R., Xu Y., Shi G.M., Fan J., Zhou J., Ji Y., et al. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection. Clin. Cancer Res 2008, 14:3850-3859.
24. Llovet J.M., Di Bisceglie A.M., Bruix J., Kramer B.S., Lencioni R., Zhu A.X., et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J. Natl. Cancer Inst 2008, 100:698-711.
25. Zhou S., Tan C., Dai Z., Zhu H., Xu M., Zhou Z., et al. Tacrolimus enhances the invasion potential of hepatocellular carcinoma cells and promotes lymphatic metastasis in a rat model of hepatocellular carcinoma: involvement of vascular endothelial growth factor-C. Transplant. Proc 2011, 43:2747-2754.
26. Tian J., Tang Z.Y., Ye S.L., Liu Y.K., Lin Z.Y., Chen J., et al. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br. J. Cancer 1999, 81:814-821.
27. Gao Q., Qiu S.J., Fan J., Zhou J., Wang X.Y., Xiao Y.S., et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J. Clin. Oncol 2007, 25:2586-2593.
28. Zhou S.L., Dai Z., Zhou Z.J., Chen Q., Wang Z., Xiao Y.S., et al. CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils. Carcinogenesis 2014, 35:597-605.
29. Zhou B.P., Deng J., Xia W., Xu J., Li Y.M., Gunduz M., et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol 2004, 6:931-940.
30. Wu Y., Deng J., Rychahou P.G., Qiu S., Evers B.M., Zhou B.P. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 2009, 15:416-428.
31. Yang W., Schraw W.P., Mueller S.G., Richmond A. Interruption of G protein-coupling in CXCR2 does not alter ligand binding, but eliminates ligand-activation of GTPgamma35S binding, calcium mobilization, and chemotaxis. Biochemistry 1997, 36:15193-15200.
32. Reiland J., Furcht L.T., McCarthy J.B. CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor. Prostate 1999, 41:78-88.
33. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
34. Janda E., Lehmann K., Killisch I., Jechlinger M., Herzig M., Downward J., et al. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol 2002, 156:299-313.
35. Fischer A.N., Herrera B., Mikula M., Proell V., Fuchs E., Gotzmann J., et al. Integration of ras subeffector signaling in TGF-beta mediated late stage hepatocarcinogenesis. Carcinogenesis 2005, 26:931-942.